|
Market Closed -
NYSE
23:00:00 21/08/2026 +03
|
5-day change | 1st Jan Change | ||
| 1.100 USD | -1.79% |
|
+5.77% | -19.12% |
| 08-15 | Actinium Pharmaceuticals Expands Manufacturing Capacity for Actimab-A Program | CI |
| 08-15 | Actinium Pharmaceuticals, Inc. Amends Its Investigational New Drug | CI |
Chart: Technical Analysis
Stock exchange
NYSE
ATNM 1.100 $
-1.79%
158K
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
NYSE
| ATNM | 1.100USD | -1.79% | 158K $ | |
Tradegate
| 7AY1 | 0.9510EUR | 0.00% | 35.18K € | |
|
Deutsche Boerse AG
| 7AY1 | 0.9240EUR | -2.12% | 4.67K € | |
|
CBOE
| ATNM | 1.110USD | -0.89% | 727.05 $ | |
|
Börse Stuttgart
| 7AY1 | 0.9330EUR | 0.00% | 0 € | |
|
Boerse Muenchen
| 7AY1 | 0.9600EUR | +2.67% | 0 € |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Neutral | Bearish |
| Resistance | 1.13 | 1.52 | 1.18 |
| Spread/Res. | -2.65% | -27.63% | -6.78% |
| Spread/Supp. | +19.32% | +46.92% | +37.95% |
| Support | 0.9219 | 0.7487 | 0.7974 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- ATNM Stock
- Charts Actinium Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
